Search results
College Students' AI Study Tool Nets $10,000 Prize—Then They Got Suspended
PC Magazine· 7 days agoAn Emory University student is suing the school after it suspended him for creating an AI studying...
Hey, Mineral Sunscreen Doesn't Have to Suck—These 10 Picks Are Proof
Cosmopolitan via Yahoo News· 5 days agoThe best mineral sunscreens offer moisturizing ingredients and gentle sun protection without a white...
Why Renee Elise Goldsberry loves that perfect twist to Wickie’s backstory on ‘Girls5eva’ [Exclusive...
Gold Derby via Yahoo News· 5 days agoFor two seasons, “Girls5eva” fans got little pieces here and there about the upbringing of resident...
Syra Health expands with new Washington State contract By Investing.com
Investing.com· 18 hours agoSyra Health Corp. (NASDAQ: SYRA) announced today that it has been awarded a new contract by the...
American Legion Post 102 shows respect for fallen soldiers - The Roanoke-Chowan News-Herald
Roanoke-Chowan News-Herald· 15 hours agoPerhaps it was ironic that a thunderstorm passed over Ahoskie late Monday morning. The storm was...
Third time will be the Emmy charm for ‘The Morning Show’
Gold Derby via Yahoo News· 7 days agoApple TV’s flagship series “The Morning Show” returned last fall for a third season with Jennifer...
Reese Witherspoon (‘The Morning Show’) will be Emmy bound again
Gold Derby via Yahoo News· 5 days agoReese Witherspoon is one half of a dynamic duo in Apple TV’s flagship series “The Morning Show,”...
Roblox CTO Daniel Sturman sells shares worth over $356k By Investing.com
Investing.com· 7 days agoRoblox Corp (NYSE:RBLX) Chief Technology Officer Daniel Sturman recently engaged in transactions...
The 8 Best Bodysuits To Shop This Summer, According To Fashion Editors
Women's Health via Yahoo News· 6 days agoWe put eight bodysuits to the test to find the best for all body types, including tall women. Some...
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
Benzinga· 1 day agoHELSINKI, Finland, May 28, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces that it will present two abstracts at the American